XML 69 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Related Parties Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
May 08, 2020
Jun. 16, 2022
Jan. 31, 2022
Jul. 19, 2017
Feb. 24, 2015
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2019
Dec. 31, 2018
Dec. 01, 2021
Sep. 30, 2021
Sep. 07, 2021
Jul. 01, 2021
Jul. 01, 2020
Related Parties Transactions (Details) [Line Items]                                
Current amount   $ 1,000,000                            
Bears interest   5.00%                            
Working capital percentage   6.40%                            
Conversion price, description   The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.                            
Balance of outstanding loans           $ 500,000   $ 500,000 $ 33,520              
Accrued interest           $ 19,984   13,819 13,701              
Due from rgene amounted                 1,889              
Maturity date       Jul. 18, 2019   Nov. 30, 2022                    
Loan agreement total amount     $ 507,000                          
loan agreements           $ 88,091                    
Interest rate     6.50%                          
Research fee           308,650.58                    
Loan agreement, description                     The advances bear interest rate of 12% per annum.          
Due amount           113,863   112,822                
Outstanding advance           525,104   188,753                
Outstanding principal and accrued interest           152,848   151,450 168,131              
Interest expenses           4,896 $ 5,312 $ 21,378 $ 22,779              
Discount of stock price                 12.00%              
Related parties transactions, description   the Company entered into a one-year convertible loan agreement with Rgene, with a principal amount of $1,000,000 to Rgene which bears interest at 5% per annum for the use of working capital that, if fully converted, would result in ABVC owning an additional 6.4% of Rgene. The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross-default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.                            
Interest rate percentage               6.50%                
Due from amount               $ 112,822 $ 124,972              
Aggregated amount $ 150,000                              
Advanced amount $ 150,000                              
Minimum [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Ownership percentage               0.00%                
Interest rate               12.00%                
Maximum [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Ownership percentage               1.00%                
Interest rate               13.6224%                
BioFirst (Australia) [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Balance of outstanding loans           313,606   $ 275,901                
Accrued interest           $ 1,132,070                    
Due from rgene amounted                       $ 250,000       $ 361,487
Interest rate percentage                         6.50%      
Loan settled amount                             $ 67,873  
Ownership percentage           6.50%                    
Research fee               1,028,556                
Aggregate working capital               275,901 132,443              
Jiangs [Member] | Minimum [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Ownership percentage           0.00%                    
Jiangs [Member] | Maximum [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Ownership percentage           1.00%                    
BHK Co Development Agreement [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Loan agreement, description         The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.                      
BioFirst [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Balance of outstanding loans               188,753 188,753              
Accrued interest               $ 40,878 40,878              
Interest rate               1.00%                
Loan agreement, description                   The advances bear interest 1% per month (or equivalent to 12% per annum).            
Discount of stock price               12.00%                
Loan               $ 147,875 147,875              
Jiangs [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Outstanding advance           $ 19,789   19,789 18,750              
Rgene [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Accrued interest               13,819                
Due from rgene amounted                 $ 49,110              
Interest rate                 1.00%              
BioFirst (Australia) [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Accrued interest               $ 1,028,556 $ 491,816              
Due from rgene amounted                       $ 250,000       $ 361,487
Maturity date               Nov. 30, 2022                
Ownership percentage               6.50%                
Interest rate percentage                         6.50%      
Total loan amount                           $ 67,873    
BHK Co Development Agreement [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Loan agreement, description         The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.                      
BioLite Japan [Member]                                
Related Parties Transactions (Details) [Line Items]                                
Outstanding advance               $ 0 $ 150,000              
Interest rate percentage 0.00%